Clinical Trial Update: Safety and Efficacy Assessment of Monoprost® in Comparison With Lumigan® 0.01 % and Lumigan® 0.03% Unit Dose [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Monoprost with Lumigan formulations for safety and efficacy in primary open angle glaucoma and ocular hypertension; results completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Lumigan (bimatoprost)
• Monoprost (unavailable)

Snippet

Sponsor: Laboratoires Thea | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2020-04-02